Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Molecular function
- GO: Biological process
- GO: Cellular component
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: fbn2a ENSDARG00000051896

.

Description

fibrillin 2a [Source:ZFIN;Acc:ZDB-GENE-090112-4]

Gene Synonyms

fbn4, fibrillin 4

Location

Chromosome 10: 16,313,851-16,474,216 reverse strand.

GRCz11:CM002894.2

About this gene

This gene has 3 transcripts (splice variants), 156 orthologues and 2 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000073604.6	fbn2a-201	8283	2760aa	ENSDARP00000068094.6	Gene/transcipt that contains an open reading frame (ORF).Protein coding	F1QNG9	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000149104.2	fbn2a-202	4067	1208aa	ENSDARP00000123990.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	F8W453	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000149392.2	fbn2a-203	325	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-

.

Summary

.

.